Calcitonin (Salmon) 2200 IU Nasal Spray — Nasal Spray
WHO-GMP Certified Commercial Pack · Product Code: AKP-073

Calcitonin (Salmon) 2200 IU Nasal Spray

Formulation Overview: Intranasal polypeptide calcium-regulating spray inhibiting osteoclastic bone resorption and providing centrally mediated analgesia in painful osteoporotic vertebral compression fractures. Formulated with Calcitonin (Salmon) Synthetic BP / USP 2200 IU/ml (2200 IU/ml (200 IU/spray)) in Metered-Dose Peptide Nasal Spray dosage form under Endocrine & Supportive Care, manufactured to IP / BP / USP Compendial standards and supplied in 14 / 30 Metered Doses Glass Spray Vial with Precision Pump Actuator with complete eCTD/ACTD regulatory dossiers, Zone IVb stability, and batch CoA for African NRAs (NAFDAC, PPB, SAHPRA, TMDA, FDA Ghana) and global tenders.
Item Code (SKU)AKP-073
Therapeutic SectorEndocrine & Supportive Care
Dosage FormMetered-Dose Peptide Nasal Spray
Active IngredientCalcitonin (Salmon) Synthetic BP / USP 2200 IU/ml
Strength / Purity2200 IU/ml (200 IU/spray)
Clinical IndicationPostmenopausal osteoporosis pain & vertebral bone loss, Paget's bone disease, and hypercalcemia
Specification StandardIP / BP / USP Compendial
Packaging Format14 / 30 Metered Doses Glass Spray Vial with Precision Pump Actuator
Shelf Life24–36 Months
Storage ConditionsStore refrigerated at 2°C–8°C prior to opening; store below 25°C during 30-day use
Minimum Order Quantity1000 Packs
Regulatory / Analytical DocsFull eCTD / ACTD Modules 1–5 + Zone IVb Stability Available
African & Global NRA ReadinessNAFDAC (Nigeria), PPB (Kenya), SAHPRA (SA), TMDA (Tanzania), FDA Ghana, AIRP, ARP, EFDA
Stock AvailabilityIn Stock · Immediate Commercial Dispatch
Supply StatusCommercial Export Ready

Related Nasal Spray & Endocrine & Supportive Care